Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2013 20:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Presentation of Results on Lubiprostone in Pediatric Functional Constipation at NASPGHAN 2013

BETHESDA, Md., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced the presentation of results from a Phase 3, open-label safety and efficacy...
October 08, 2013 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Clinical Data Show That Lubiprostone is Efficacious and Well Tolerated in Children and Adolescents With Functional Constipation

BETHESDA, Md., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), today announced clinical data showing that lubiprostone is efficacious and well tolerated in...
September 27, 2013 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo to Present Data on AMITIZA(R) (Lubiprostone) in Opioid-Induced Constipation at 24th Annual AAPM Meeting

BETHESDA, Md., Sept. 27, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced the poster presentation of data evaluating the long-term safety of...
September 20, 2013 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at BioCentury(R) NewsMakers in the Biotech Industry 2013 Conference

BETHESDA, Md., Sept. 20, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
September 12, 2013 19:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo to Present Data on AMITIZA(R) (lubiprostone) in Chronic Idiopathic Constipation at Annual Meeting of the Swiss Society of Gastroenterology

BETHESDA, Md., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Sucampo AG ("SAG"), a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), announced today that it will present four...
September 04, 2013 20:05 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo to Present Results From Four Phase 3 Studies of AMITIZA(R) (lubiprostone) for Opioid-Induced Constipation at PAINWeek 2013

BETHESDA, Md., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") will be presenting data from four separate phase 3 studies evaluating the overall efficacy of...
August 08, 2013 16:01 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals, Inc. Reports Second Quarter and Six Months 2013 Financial and Operating Results

Company Reports Profitable Quarter and Will Provide Earnings Guidance Company to Host Conference Call Today at 5:00 pm Eastern BETHESDA, Md., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Sucampo...
August 08, 2013 16:01 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Begins Search for New CEO

BETHESDA, Md., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced that it has begun the search for a new Chief Executive Officer (CEO). Sucampo...
August 07, 2013 20:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Positive Top-Line Results in Phase 1a Trials of Cobiprostone and SPI-3608

BETHESDA, Md., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) (Sucampo) today announced the positive top-line results of two recently completed clinical trials, a Phase...
July 25, 2013 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Second Quarter and Six Months 2013 Results and Operating Highlights Teleconference and Webcast

BETHESDA, Md., July 25, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), a global biopharmaceutical company, today announced that it will host a webcast and...